> All the big AIM fraud exposés
> 300 articles and podcasts a month
> Hot share tips
> Original investigations by our experienced team
> No ads, no click-bait, no auto-play videos
By Tom Winnifrith | Saturday 28 January 2017
Disclosure: I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from ShareProphets). I have no business relationship with any company whose stock is mentioned in this article.
If I sound more like my father that is a good thing for he is honest and precise in his use of language, although he would not use some of the "french phrases" which occur in this podcast. I discuss the use of language and how wording has an exact meaning - this is in relation to Coral Products (CRU) which needs to clarify something. I do not think it is a fraud and it can easily blame its useless Nomad Cairn. After what it has signed off for Cloudtag (CTAG) few will fail to accept such an excuse. I then move onto deliberate lying by AIM Companies which is actually quite rare. Gross over-promotion is quite common. I explain the difference. Cloudtag and Advanced Oncotherapy (AVO) are mentioned in detail in this section. In discussing what is a fact I refer to my article of yesterday on Holocaust Memorial Day which is HERE
Already registered? Click here to sign in
This area of the ShareProphets.com site is for independent financial commentary. These blogs are provided by independent authors via a common carrier platform and do not represent the opinions of ShareProphets.com. ShareProphets.com does not monitor, approve, endorse or exert editorial control over these articles and does not therefore accept responsibility for or make any warranties in connection with or recommend that you or any third party rely on such information. The information available at ShareProphets.com is for your general information and use and is not intended to address your particular requirements. In particular, the information does not constitute any form of advice or recommendation by ShareProphets.com and is not intended to be relied upon by users in making (or refraining from making) any investment decisions.
Search ShareProphets |
Stock market news |
Recent Comments |
Site by Everywhen